Arthrocare (ARTC) Enters Oversold Territory

ArthroCare (ARTC) share price has entered into oversold territory with a stochastic value of 19.06. The Zacks Consensus Estimate on the company’s earnings for 2010 moved up 7 cents over the past 2 months to 89 cents per share. Arthrocare is a Zacks #2 Rank (“Buy”) company.

ARTHROCARE CORP (ARTC): Free Stock Analysis Report
Zacks Investment Research

About Zacks Investment Research 1767 Articles

Zacks Investment Research is one of the most highly regarded firms in the investment industry. In 1978 Zacks originated the concept of utilizing earnings estimates revisions to make profitable investment decisions. Zacks offers multiple investment products and services to help investors achieve superior returns.


Be the first to comment

Leave a Reply

Your email address will not be published.